We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
United Parks & Resorts
PRKS
$2.21B
| $32.8M | 0.15% |
657,200
-354,145
| -35% | -$18.8M |
|
177
Exelixis
EXEL
$14.2B
| $32.8M | 0.15% |
1,797,500
+111,246
| +7% | +$2.59M |
|
|
SEM
178
DELISTED
Select Medical
SEM
| $32.7M | 0.15% |
1,436,733
-1,966,100
| -58% | -$40.8M |
|
179
US Foods
USFD
$22.3B
| $32.7M | 0.15% |
852,310
-720,498
| -46% | -$27.9M |
|
180
Sarepta Therapeutics
SRPT
$1.63B
| $32.5M | 0.15% |
418,600
+279,614
| +201% | +$21.2M |
|
181
Dell
DELL
$253B
| $32.2M | 0.14% |
638,266
-2,292,428
| -78% | -$115M |
|
182
DigitalBridge
DBRG
$2.93B
| $32.2M | 0.14% |
1,017,529
+472,116
| +87% | +$13.5M |
|
183
Kohl's
KSS
$2.16B
| $32.1M | 0.14% |
581,642
+92,797
| +19% | +$5.34M |
|
184
Icon
ICLR
$13.9B
| $32M | 0.14% |
+155,000
| New | +$33.4M |
|
|
MREO
185
Mereo BioPharma
MREO
$48.2M
| $32M | 0.14% |
10,107,189
+1,830,689
| +22% | +$6.14M |
|
186
ASML
ASML
$608B
| $32M | 0.14% |
46,300
+10,900
| +31% | +$7.19M |
|
187
Exelon
EXC
$48.4B
| $31.9M | 0.14% |
1,008,581
+150,697
| +18% | +$4.85M |
|
188
Targa Resources
TRGP
$56.2B
| $31.9M | 0.14% |
716,527
+23,905
| +3% | +$925K |
|
|
CLR
189
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $31.6M | 0.14% |
832,136
-39,623
| -5% | -$1.23M |
|
|
RCM
190
DELISTED
R1 RCM Inc. Common Stock
RCM
| $31.3M | 0.14% |
1,405,495
+1,010,468
| +256% | +$24.4M |
|
191
Occidental Petroleum
OXY
$53.6B
| $31.2M | 0.14% |
998,931
-450,025
| -31% | -$12.1M |
|
192
Chubb
CB
$141B
| $31.1M | 0.14% |
195,536
-142,108
| -42% | -$23.6M |
|
193
Cable One
CABO
$249M
| $31M | 0.14% |
+16,193
| New | +$29.1M |
|
194
BioMarin Pharmaceuticals
BMRN
$12B
| $30.6M | 0.14% |
366,500
+110,000
| +43% | +$8.72M |
|
195
Keurig Dr Pepper
KDP
$42.3B
| $30.1M | 0.14% |
853,590
+630,337
| +282% | +$22.5M |
|
196
McCormick & Company Non-Voting
MKC
$13.9B
| $29.9M | 0.13% |
338,677
+254,724
| +303% | +$22.7M |
|
197
Builders FirstSource
BLDR
$7.93B
| $29.9M | 0.13% |
700,240
+612,999
| +703% | +$28.4M |
|
|
AVLR
198
DELISTED
Avalara, Inc.
AVLR
| $29.9M | 0.13% |
+184,506
| New | +$25.7M |
|
|
AKRO
199
DELISTED
Akero Therapeutics
AKRO
| $29.6M | 0.13% |
1,191,700
+685,203
| +135% | +$19.2M |
|
200
Golar LNG
GLNG
$4.95B
| $29.5M | 0.13% |
+2,225,400
| New | +$26.5M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.